Walter J. Curran
Silvia C. Formenti
The American Society for Radiation Oncology honored three of its members with the Gold Medal Award.
This year’s recipients were Walter J. Curran, MD; Silvia Chiara Formenti, MD, FASTRO; and Thomas Rockwell Mackie, PhD, professor of medical physics at University of Wisconsin.
ASTRO Gold Medals — the highest honor bestowed upon ASTRO members — are presented to individuals who made outstanding lifetime contributions in the field of radiation oncology. They recognize work in research, clinical care, service and teaching.
This year’s honorees received their awards at ASTRO Annual Meeting, held Sept. 15-18 in Chicago.
Curran — a HemOnc Today Editorial Board Member — is executive director of Winship Cancer Institute at Emory University. He holds the Lawrence W. Davis chair of radiation oncology at Emory, and he was the first radiation oncologist to serve as director of an NCI-designated cancer center.
Thomas R. Mackie
"ASTRO is an extraordinary organization, and I am deeply honored by this award,” Curran said in an Emory-issued press release. “This award also recognizes my outstanding colleagues in cancer research and education in support of our patients.”
Formenti is chair of the department of radiation oncology and the Sandra and Edward Meyer professor of cancer research at Weill Cornell Medicine. She also is radiation oncologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center.
“I’m honored to receive this award,” Formenti said in a Weill Cornell-issued press release. “It’s gratifying that my peers recognize the discoveries and the progress in cancer treatment we have made at Weill Cornell Medicine and NewYork-Presbyterian. It really has been a team effort.”
Mackie is professor emeritus of engineering, medical physic and human oncology at University of Wisconsin (UW) Carbone Cancer Center. He now serves as UW Health’s chief innovation officer and head of the Isthmus Project, the health system’s new innovation accelerator.
“Rock Mackie is a brilliant thinker and inventor,’’ Paul Harari, MD, chairman of ASTRO’s board of directors and chairman of UW’s department of human oncology, said in an institution-issued press release. “His innovations in radiation oncology have had an enormous impact on the precision of cancer treatment worldwide. We are very fortunate to have had this highly creative scientist working at the University of Wisconsin over the last 30 years.”